The store will not work correctly when cookies are disabled.
rac-2-(4-((1H-imidazol-4-yl)methyl)-5-phenyl-4,5-dihydrothiazol-2-yl)phenol
ID: ALA4209942
PubChem CID: 145963830
Max Phase: Preclinical
Molecular Formula: C19H17N3OS
Molecular Weight: 335.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Oc1ccccc1C1=NC(Cc2c[nH]cn2)C(c2ccccc2)S1
Standard InChI: InChI=1S/C19H17N3OS/c23-17-9-5-4-8-15(17)19-22-16(10-14-11-20-12-21-14)18(24-19)13-6-2-1-3-7-13/h1-9,11-12,16,18,23H,10H2,(H,20,21)
Standard InChI Key: BDLSNMGOWYNTSL-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
29.2961 -14.4156 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.1251 -14.4156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3850 -13.6275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7127 -13.1402 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
29.0426 -13.6275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2613 -13.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0900 -12.5671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3024 -12.3104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6850 -12.8642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8632 -13.6797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6464 -13.9306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7027 -12.0147 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6085 -15.0839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4291 -14.9995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9775 -15.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7318 -15.2816 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6473 -14.4611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8409 -14.2879 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.1688 -13.3740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7809 -13.9286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5652 -13.6757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7387 -12.8683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1216 -12.3145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3397 -12.5704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
5 6 1 0
7 12 1 0
2 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 2 0
18 14 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
3 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 335.43 | Molecular Weight (Monoisotopic): 335.1092 | AlogP: 3.96 | #Rotatable Bonds: 4 |
Polar Surface Area: 61.27 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.61 | CX Basic pKa: 6.53 | CX LogP: 4.43 | CX LogD: 4.38 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.76 | Np Likeness Score: 0.44 |
References
1. Lin Z, Smith MD, Concepcion GP, Haygood MG, Olivera BM, Light A, Schmidt EW.. (2017) Modulating the Serotonin Receptor Spectrum of Pulicatin Natural Products., 80 (8): [PMID:28745513] [10.1021/acs.jnatprod.7b00317] |